Advertisement

Topics

Companies Related to "NASPI: N-Acetylcysteine vs. Ascorbic Acid for Prevention of Contrast Induced Nephropathy in Renal Insufficiency Undergoing Coronary Catheterization" [Most Relevant Company Matches] RSS

18:52 EST 16th February 2019 | BioPortfolio

Here are the most relevant search results for "NASPI: N-Acetylcysteine vs. Ascorbic Acid for Prevention of Contrast Induced Nephropathy in Renal Insufficiency Undergoing Coronary Catheterization" found in our extensive corporate database of over 50,000 company records.

Showing "NASPI Acetylcysteine Ascorbic Acid Prevention Contrast Induced Nephropathy" Companies 1–25 of 1,000+

Extremely Relevant

Osprey Medical Inc.

Osprey Medical's core technologies originated from research conducted by Dr David Kaye at Melbourne’s Baker IDI Heart and Diabetes Institute. Osprey is focused on improving patients’ quality of life by protecting those with chronic kidney disease from contrast induced nephropathy (CIN) and preventing limb amputation in diabetic patients with advanced ...


CorMedix Inc.

CorMedix Inc. is a pharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the prevention and treatment of cardiac and renal dysfunction, also known as cardiorenal disease. CorMedix’s goal is to treat kidney disease by reducing the commonly associated cardiovascular and metabolic complications, in effect, tr...

Relevant

CardioLogical Solutions

Privately held CardioLogical Solutions is an emerging medical technology company focused on developing novel accessory devices for interventional cardiology procedures. For example, the recent emergence of transcatheter aortic valve replacement (TAVR) therapies has created a critical need for non-surgical, large-hole (>12 Fr) access and closure technologie...


Ischemix, Inc.

Ischemix is a privately-held, clinical-stage pharmaceutical company developing novel cytoprotective compounds for the prevention and treatment of serious diseases and conditions. The initial focus of the Company is the prevention of acute kidney injury and cardiac injury in patients undergoing cardiac catheterization procedures. Ischemix’ lead product...

Osprey Medical, Inc.

Osprey Medical is a privately held company located in Eden Prairie, Minnesota. The Company is dedicated to the treatment and prevention of ailments originating from the inter-related functioning of the heart and kidneys with a primary focus on CIN. The Company’s CINCOR™ Contrast Removal System is a catheter based system that is designed to remove ...

DiObex, Inc.

DiObex is a biotechnology company engaged in the development of novel products for metabolic disease. DIO-901 (very low dose glucagon) is in development in two convenient delivery forms for the prevention of nocturnal hypoglycemia induced by insulin intensification. Insulin-induced hypoglycemia, which occurs most frequently at night, is a major limitation in the aggressive management of hype...

MonoSol Rx, LLC

MonoSol Rx is a specialty pharmaceutical company leveraging its proprietary PharmFilm® technology to deliver drugs in films. PharmFilm® is designed to benefit patients by improving the convenience, efficacy, and compliance of new and currently marketed drugs. The Company's leadership in film drug delivery is supported by strong intellectual property, a portfolio of commercialized prescription an...

Advanced Magnetics Incorporated

Advanced Magnetics, Inc., develops, manufactures and markets organ-specific contrast agents to improve the diagnostic capabilities of soft tissue magnetic resonance imaging ("MRI") scans. Sales of the Company's liver contrast agent, FeridexI.V.(R), have commenced in Europe, Japan, the United States, Argentina, South Korea and Israel. The product is approved and awaiting market launch in China. Sal...

Donboo Amino Acid Co., Ltd

Donboo Amino Acid Co., Ltd is an enterprise with advanced science and technology. We specialize in scientific research, manufacture & trade of amino acids and its derivations. It is over 10 years since we were devoted to the scientific research and development of amino acid. We have now established friendly trade contacts with many amino acid factories throughout the P.R.China. With a fully-ranged...

Fibrotech Therapeutics

Fibrotech is an Australian biopharmaceutical company developing a new class of drugs to prevent a massive health burden associated with fibrosis (tissue scarring). The Company develops novel anti-fibrotic drug candidates for the treatment of the fibrosis prevalent in such chronic conditions as chronic kidney disease, chronic heart failure, pulmonary fibros...

PURAC

CSM Biochemicals is a division of CSM and operates in the marketplace under the name PURAC. Our parent company, CSM, is a company operating and engaged in the development, production, sale and distribution of bakery supplies and food ingredients. CSM is listed on the Euronext stock exchange in Amsterdam. CSM has a leading market position in bakery ingredients, sugar, lactic acid/lactates ...

Nantong Acetic Acid Chemical Co., Ltd.

Nantong Acetic Acid Company limited (formerly Nantong Acetic Acid chemical factory),after 44years of creation and development,is a comprehensive chemical company producing acetic acid derivatives which is the largest in production scope and the most complete in varieties in China.its main product include more then 30 varieties in four series such as organic raw materials,pharmaceutical intermediat...

ProCertus BioPharm, Inc.

ProCertus BioPharm is an oncology-based pharmaceutical company whose primary mission is to protect cancer patients against the side effects of chemotherapy and radiotherapy.ProCertus has established proof of concept in animal models for its product candidates, DermX, ProDermaCel™, and OralX, proprietary pharmaceuticals designed to reduce or eliminate the side effects associated with cancer thera...

Omthera Pharmaceuticals, Inc.

Omthera Pharmaceuticals, Inc. is a specialty pharmaceuticals company with an experienced team of experts in drug development focusing its efforts on the clinical development of new therapies for dyslipidemia. The lead product candidate is Epanova™, an Omega-3 fatty acid containing a novel formulation of eicosapentaenoic acid (EPA) and docosahexaenoic ...

Endra Life Sciences

Endra Inc., based in Ann Arbor, MI, is dedicated to the commercialization of photoacoustic imaging, a groundbreaking approach enabling rapid, high contrast, high resolution functional and anatomical imaging at depth, without the need for contrast agents. Endra technologies provide fast, simple non-invasive solutions for quantification of tumor vasculature, blood oxygen saturation, and imaging o...

The Gout & Uric Acid Education Society

Formed in September 2005, the Gout & Uric Acid Education Society has a comprehensive educational brochure, as well as a user-friendly Web site for patients, caregivers, family members and health care providers. For more information about gout and the Gout & Uric Acid Education Society, please visit www.gouteducation.org.

Prevention

Prevention is the #1 healthy lifestyle brand in the U.S., with a magazine audience of more than 10.2 million readers as well as the top online health magazine destination (http://www.prevention.com) with 2.6 million unique visitors each month, 22 million page views and 1.3 million in newsletter distribution. Prevention also publishes branded books—mos...

Chlorhexidine Partners Network

The Chlorhexidine Partners Network was created by manufacturers of patient safety technology to support chlorhexidine as an infection prevention molecule. Each organization offers chlorhexidine solutions designed to protect patients from infection. The goal of the partnership is to educate the infection control community and other clinicians about the chlo...

International Bullying Prevention Association

The International Bullying Prevention Association (IBPA) aims to identify and help implement research-based and data-driven programs that reduce bullying in schools. IBPA includes educators, researchers and bullying prevention professionals and practitioners in school violence prevention from around the world. For more information, visit www.stopbullyingworld.org.

Molecular Biosystems Inc.

Molecular Biosystems, Inc. is a leader in the development, manufacture and sale of ultrasound contrast imaging agents. These contrast agents are used primarily to improve the real-time images ("moving pictures") of organs and body structures, especially the heart, obtained through ultrasound examinations. MBI's products are designed to increase the diagnosticusefulness of ultrasound examinations t...

Myriant Technologies

With a world-renowned team of molecular biologists, engineers and chemists, Myriant utilizes proprietary technology to advance the development of low-cost cellulosic sugars for the sustainable manufacturing of high-value specialty chemicals. The company's D(-) lactic acid started production at commercial scale in June 2008 for use in polylactic acid. Myriant will next begin commercial production o...

Nucleic Acid Purifications (NAP)

Nucleic Acid Purifications (NAP) provides genomic DNA, RNA, mRNA (whole blood and tissue), and plasmid DNA purification, and isolation services for genotyping/expression (microarray) studies.

Transgenomics Incorporated

Cruachem Ltd is a leader in nucleic acid chemistry. We offer custom DNA and RNA oligonucleotides, DNA and RNA synthesis reagents, and contract nucleic acid manufacturing from R & D scale to Kg scale.

National Action Alliance for Suicide Prevention

WHAT: The National Action Alliance for Suicide Prevention (Action Alliance) and other leaders from both the public and private sectors will release the National Strategy for Suicide Prevention on Monday, September 10, 2012. The National Strategy for Suicide Prevention, a report of the Surgeon General and the Action Alliance features community-based approac...

Myriant Corporation

Myriant utilizes proprietary technology to provide innovative, performance-based renewable chemicals utilizing low-cost sugars. In December 2010, Myriant broke ground on its 30 million pound commercial succinic acid facility in Lake Providence, Louisiana. The company’s D(-) lactic acid started production at commercial scale in June 2008 for use in pol...


More From BioPortfolio on "NASPI: N-Acetylcysteine vs. Ascorbic Acid for Prevention of Contrast Induced Nephropathy in Renal Insufficiency Undergoing Coronary Catheterization"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks